Barinthus Biotherapeutics (BRNS) EBIT Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 100.00% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 12.69% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 75.16% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -347.04% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 1.27% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -230.00% |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 80.62% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | 70.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.51% |
| Dec 31, 2025 | 50.56% |
| Sep 30, 2025 | -60.62% |
| Jun 30, 2025 | -27.55% |
| Mar 31, 2025 | -21.79% |
| Dec 31, 2024 | -17.02% |
| Sep 30, 2024 | 41.76% |
| Jun 30, 2024 | 30.57% |
| Mar 31, 2024 | 21.27% |
| Dec 31, 2023 | 20.34% |
| Sep 30, 2023 | -322.57% |
| Jun 30, 2023 | -299.00% |
| Mar 31, 2023 | -3,385.02% |
| Dec 31, 2022 | -50.55% |
| Sep 30, 2022 | 230.71% |
| Jun 30, 2022 | 178.57% |
| Mar 31, 2022 | 110.60% |
| Dec 31, 2021 | -73.03% |
| Sep 30, 2021 | -287.68% |
| Jun 30, 2021 | -288.49% |